Cite
MLA Citation
Eileen M. Boyle et al.. “Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial.” British journal of haematology, vol. 187, 2019, pp. 319–327. http://access.bl.uk/ark:/81055/vdc_100094617029.0x00005e